Common biological factors implicated in benign prostatic hyperplasia and prostate cancer, conventional and phytotherapeutic approaches employed in management: A review
Abstract
Introduction: Benign prostate hyperplasia (BPH) and Prostate cancer (PC) are diseases affecting the prostate glands of aging men. Objective: We reviewed common biological factors in BPH and PC, conventional and phytotherapeutic approaches employed in both conditions. Method: PubMed, Google Scholar and Web of Science databases were used to search for information using key words, “Common biological factors in BPH and PC”, “Conventional approach used in BPH and PC”, and “Medicinal plants used in BPH and PC”. All 174 articles included in this review were from 1942 to 2023, published in English language as original articles or reviews. Result: Inflammation, hormones and apoptosis are implicated in both conditions. Conventional interventions include watchful waiting, active surveillance, chemotherapy, immunotherapy, radiotherapy advanced definitive therapies and surgery. Phytotherapy including Saw palmetto believed to inhibit type 1 and 2 isoenzymes of 5α-reductase, Prunus africana which possesses anti-inflammatory activity, inhibits synthesis of prostaglandins, aromatase and 5α-reductase activity, suppresses growth factors of the prostate and cholesterol build-up, disrupts congestion of blood vessel, reduce excessive blood, decrease prostate adenoma size, and inhibit cell proliferation in the prostate gland; Urtica dioica, Epilobolium rosmarinifolium, Vitex agnus, amongst others have reportedly demonstrated potentials against BPH and PC. Conclusion: Researchers give more attention…
Read the paper
Related studies
- Treatment of non-metastatic castration-resistant prostate cancer: facing age-related comorbidities and drug–drug interactions
- The Efficacy of Flogofilm® in the Treatment of Chronic Bacterial Prostatitis as an Adjuvant to Antibiotic Therapy: A Randomized Prospective Trial
- Inhibition of growth and contraction in human prostate stromal cells by silencing of NUAK1 and -2, and by the presumed NUAK inhibitors HTH01-015 and WZ4003
- Effectiveness and Safety of a New Nutrient Fixed Combination Containing Pollen Extract Plus Teupolioside, in the Management of LUTS in Patients with Benign Prostatic Hypertrophy: A Pilot Study
- Extract from Cucurbita pepo improves BPH symptoms without affecting sexual function: a 24-month noninterventional study
- Aquablation vs. holmium laser enucleation of the prostate for benign prostatic hyperplasia: a 150-patients prospective comparative multicenter study
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.